For a 63‑year‑old woman with an isolated anterior pelvic ring fracture, is naproxen (Aleve) or ketorolac (Toradol) the preferred oral NSAID for pain management?

Naproxen (Aleve) is Preferred Over Ketorolac (Toradol) for Pain Management in This Patient

For a 63-year-old woman with an isolated anterior pelvic ring fracture, naproxen (Aleve) is the preferred oral NSAID over ketorolac (Toradol) due to the patient's age-related risk factors and the limited duration for which ketorolac can be safely used.

Key Considerations for NSAID Selection in This Patient

Age-Related Risk Profile

• This patient is at high risk for NSAID toxicities given her age of 63 years, which exceeds the threshold of 60 years identified in guidelines for increased risk of renal, gastrointestinal, and cardiac complications 1.
• Patients over 60 years have significantly elevated risks of peptic ulcer disease, gastrointestinal hemorrhage, renal toxicity (including interstitial nephritis and papillary necrosis), and cardiovascular complications when using NSAIDs 1.

Ketorolac-Specific Limitations

• Ketorolac is explicitly recommended only for short-term use (maximum 5 days) in clinical guidelines 1.
• The FDA drug label for ketorolac emphasizes that prolonged use, especially in elderly patients receiving high doses, markedly increases the risk of serious gastrointestinal bleeding 2.
• A large postmarketing study demonstrated that ketorolac's risk of clinically serious GI bleeding is dose-dependent and particularly elevated in elderly patients receiving average daily doses greater than 60 mg/day 2.
• Ketorolac has a delayed onset of analgesic action (30-60 minutes) and more than 25% of patients exhibit little or no response in acute pain settings 3.

Naproxen Advantages for This Clinical Scenario

• Naproxen can be used for the extended duration required for pelvic fracture healing without the 5-day limitation that restricts ketorolac 1.
• Isolated anterior pelvic ring fractures are stable injuries typically managed conservatively with adequate analgesia and guided mobilization, requiring pain control beyond 5 days 4.
• Guidelines recommend using "any NSAID that the patient has found effective and tolerated well in the past" as first-line therapy, with ibuprofen (structurally similar to naproxen) specifically mentioned before considering ketorolac 1.

Evidence-Based Approach to Pain Management

Multimodal Analgesia Strategy

• Initiate acetaminophen as first-line therapy (650-1000 mg every 6 hours, maximum 4 g/24 hours) given its superior safety profile in older adults compared to NSAIDs 1.
• Add naproxen if acetaminophen alone is insufficient for pain control, as NSAIDs are effective for treating all intensities of pain in the short term unless contraindicated 1.
• The 2024 World Society of Emergency Surgery guidelines strongly recommend regular administration of intravenous acetaminophen every 6 hours as first-line treatment in managing acute trauma pain in the elderly, with NSAIDs added for severe pain while considering potential adverse events 1.

Monitoring Requirements for NSAID Use

• Baseline assessment required: blood pressure, BUN, creatinine, liver function studies (alkaline phosphatase, LDH, SGOT, SGPT), CBC, and fecal occult blood 1.
• Discontinue NSAIDs if: BUN or creatinine doubles, hypertension develops or worsens, liver function studies increase above normal limits, or signs of gastrointestinal bleeding occur 1.
• Monitor for gastric upset or nausea; consider switching to a selective COX-2 inhibitor if these develop, as they have lower incidence of GI side effects 1.

Critical Safety Considerations

When to Avoid NSAIDs Entirely

• History of peptic ulcer disease or significant alcohol use (≥2 alcoholic beverages per day) 1.
• Compromised fluid status or concomitant use of nephrotoxic drugs 1.
• History of cardiovascular disease or concurrent anticoagulant therapy (warfarin, heparin), which significantly increases bleeding risk 1.
• Thrombocytopenia or bleeding disorders 1.

Bone Healing Concerns

• Short-term NSAID use (≤7 days) does not increase risk of delayed union or nonunion in orthopedic trauma 5.
• A 2023 systematic review found that NSAIDs reduce post-trauma pain and opioid requirements, with only a small effect on non-union rates (2.99% vs 2.19%, p=0.04) 6.
• The benefit of pain control and reduced opioid use appears to outweigh the small potential risk of impaired bone healing 6.

Opioid-Sparing Benefits

• NSAIDs significantly reduce opioid requirements by 25-50% when used in combination therapy 7.
• Recent evidence shows that anterior and posterior fixation combined with appropriate analgesia decreases postoperative pain and narcotic usage in pelvic ring injuries 8.
• The 2021 UK guidelines recommend weaning opioids first when reducing analgesic requirements, then stopping NSAIDs, and finally stopping acetaminophen 1.

Common Pitfalls to Avoid

• Do not prescribe ketorolac for longer than 5 days, as this dramatically increases adverse event risk, especially in elderly patients 1, 2.
• Do not combine NSAIDs with aspirin, as this increases protein binding displacement and potential for adverse effects without clear benefit 2.
• Do not assume pain control alone indicates adequate treatment; functional assessment and mobilization goals are equally important in pelvic fractures 4.
• Do not overlook the need for gastroprotection (proton-pump inhibitors, misoprostol) in high-risk elderly patients if NSAIDs are deemed necessary 1.